免疫系調節における超強化剤:メカニズム,病理的再プログラム,および治療の機会
Xin Lai1, Caizhi Li2, Xinglinzi Tang2
1The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Frontiers in immunology
|September 2, 2025
まとめ
スーパーエンハンサー (SE) は,免疫細胞の発達と機能を制御する重要な表遺伝的ハブです. SEの調節不良は免疫疾患に寄与しますが,SEを標的とした新しい治療法は,免疫バランスを回復する見込みを示しています.
科学分野:
- エピジェネティクスと遺伝子調節
- 免疫学と免疫細胞生物学
- システム生物学とゲノミクス
背景:
- スーパーエンハンサー (SE) は,細胞型特異的な遺伝子発現を調整する重要な表遺伝子調節剤である.
- 免疫細胞の分化,機能,可塑性を制御するために 多様な分子信号を統合します
- SEは免疫ホメオスタシスの維持に不可欠ですが,その調節不全は免疫媒介の病気に関与しています.
研究 の 目的:
- 免疫細胞の運命決定と転写制御におけるSEの役割を検討する.
- 癌,感染症,自己免疫疾患における共有の規制ネットワーク内でSEがどのように機能するか探求する.
- SEと関連する課題を対象とした新たな治療戦略について議論する.
主な方法:
- 免疫学と病気における超強化剤に関する既存の文献のレビュー.
- クロマチンのループと凝縮物形成を含む,SEの空間時間的な調節特性の分析.
- SEのダイナミクスを理解するためのマルチオミックプロファイリングと単細胞分析の議論
主要な成果:
- SEは免疫細胞の特化と適応反応に不可欠なダイナミックな表遺伝的ハブとして機能する.
- 慢性的な炎症,自己免疫,悪性腫瘍に寄与する.
- SEを標的とした新興治療法は,特異性と発現の課題にもかかわらず,免疫媒介疾患の治療の可能性を提示しています.
結論:
- SEは免疫細胞の運命と機能に因果的に影響し,保存された規制ネットワーク内で動作します.
- SEのダイナミクスを理解することは,免疫のバランスを回復するための精密な介入の開発に不可欠です.
- 先進的なマルチエミクスと治療戦略を統合した将来の研究は,SEベースの精密医療を前進させるでしょう.
関連する概念動画
Transduction
98
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
98
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Cell-mediated Immune Responses
72.2K
Overview
72.2K


